RMTI Earnings Prediction
The chart below shows how RMTI performed 10 days before and after its earnings report, based on data from the past quarters. Typically, RMTI sees a -6.66% change in stock price 10 days leading up to the earnings, and a +1.18% change 10 days following the report. On the earnings day itself, the stock moves by +4.45%. This data can give you a slight idea of what to expect for the next quarter's release.
RMTI Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
28.32M
19.12%
9.62%
Gross Margin
22.03%
137.90%
25.10%
Operating Margin
6.84%
193.57%
243.72%
Net Margin
5.88%
174.62%
342.11%
EPS
0.04
157.14%
300.00%
No Data Available
RMTI Earnings Analysis
Rockwell Medical, Inc. (DE) Common Stock Corporation (RMTI.O) Earnings Conference Call
Positive
Consistent Profitability Achievement: For the third quarter of 2024, we achieved profitability on a cash flow and adjusted EBITDA basis for the second consecutive quarter.
Record Quarterly Performance: We achieved the highest quarterly concentrate product sales, the highest quarterly gross profit, and the highest quarterly gross margin in Rockwell's history.
Net Sales Increase: Net sales for the third quarter of 2024 were $28.3 million, representing a 19% increase over net sales of $23.8 million from the same period in 2023.
Gross Profit Surge: Gross profit for Q3 2024 was $6.2 million, which represents a 183% increase over gross profit of $2.2 million for the same period in 2023.
Net Income Improvement: Net income for the third quarter of 2024 was $1.7 million compared to a net loss of $1.9 million for the same period in 2023.
Negative
Quarterly Revenue Boost: Revenue for the third quarter was positively impacted by consistent sales from our current customers as well as our largest customer making a special large order of premium products during the quarter.
Gross Profit Increase Factors: The increase in gross profit was due to higher gross margin on our current business, coupled with the special large order of premium-priced products from our largest customer.
Revenue Projection Range: We project that our revenue will be between $23 million and $25 million.
Increased 2024 Financial Guidance: We have increased our 2024 guidance for net sales to be between $98 million and $101 million, gross profit to be between $15 million and $17 million; gross margin to be between 16% and 18% and adjusted EBITDA to be between $4 million and $5 million.
Customer Makeup Shift: We expect to encounter a shift in our customer makeup as we move away from less profitable business to focus on more profitable growth opportunities.
RMTI FAQs
How does RMTI typically perform around its earnings report dates?
Is Rockwell Medical, Inc. (RMTI) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
RMTI Earning Call Sentiment
Rockwell Medical, Inc. (RMTI) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
RMTI.O
4.12%Positive
The earnings call highlights strong financial performance, including significant revenue and profit growth, improved margins, and positive cash flow. Despite dependency risk on a major customer, the company is expanding its product line and market reach, particularly in the growing at-home dialysis market. Guidance has been raised across key metrics, and management remains optimistic. However, lack of specific shareholder return plans and some uncertainties in management responses temper enthusiasm. Overall, the positive financial momentum and strategic initiatives suggest a positive stock price movement in the short term.
